Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Authors
Keywords
-
Journal
BMC Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-10
DOI
10.1186/s12916-019-1457-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alteration of specific cytokine expression patterns in patients with breast cancer
- (2019) Kosuke Kawaguchi et al. Scientific Reports
- Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system
- (2019) Amir Abbas Momtazi-Borojeni et al. ATHEROSCLEROSIS
- Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy
- (2018) Parvin Zamani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
- (2017) Christine Landlinger et al. EUROPEAN HEART JOURNAL
- P-407-induced Mouse Model of Dose-controlled Hyperlipidemia and Atherosclerosis
- (2017) Thomas P. Johnston et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers
- (2017) Alejandro Arrieta et al. JAMA Cardiology
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- A Therapeutic Peptide Vaccine Against PCSK9
- (2017) Yajie Pan et al. Scientific Reports
- Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9
- (2016) Bryce Chackerian et al. CURRENT OPINION IN LIPIDOLOGY
- Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
- (2016) Brian A. Ference et al. NEW ENGLAND JOURNAL OF MEDICINE
- A cholesterol-lowering VLP vaccine that targets PCSK9
- (2015) Erin Crossey et al. VACCINE
- New metrics needed to visualize the long-term impact of early LDL-C lowering on the cardiovascular disease trajectory
- (2015) Chris J. Packard et al. VASCULAR PHARMACOLOGY
- Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease
- (2015) Linqiang Zhang et al. Scientific Reports
- Therapeutic Vaccines for Hypertension and Dyslipidemia
- (2014) Hironori Nakagami et al. International Heart Journal
- Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
- (2014) Gergana Galabova et al. PLoS One
- New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect?
- (2013) Amirhossein Sahebkar et al. CARDIOVASCULAR DRUGS AND THERAPY
- Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
- (2013) Daniel Urban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Active immunotherapy for chronic diseases
- (2013) Martin F. Bachmann et al. VACCINE
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease
- (2012) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up
- (2011) Geertje M. Bartelds JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipid Treatment Assessment Project 2
- (2009) David D. Waters et al. CIRCULATION
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now